Search results for ' Measles Vaccine'

Clean chit to TN measles vaccine

Clean chit to TN measles vaccine

Rediff.com15 May 2008

The measles vaccine administered to children in Tamil Nadu has been given a clean chit by the Central Drugs Laboratory at Kasauli in Himachal Pradesh. Human error at the local level could have caused the deaths of four infants last month.

Zoho's Vembu Sparks Fury Over Vaccine-Autism Claim

Zoho's Vembu Sparks Fury Over Vaccine-Autism Claim

Rediff.com28 Oct 2025

A social media spat erupted on X between TheLiverDoc and Zoho Corporation's Chief Scientist, Sridhar Vembu, after the later endorsed a claim linking childhood vaccinations to autism.

One In Three Indian Women Overweight

One In Three Indian Women Overweight

Rediff.com9 Jun 2026

Over the past year, the sale of injectable GLP-1 agonists (used to treat type 2 diabetes and obesity) such as Mounjaro, Wegovy and Ozempic have surged a whopping 218 per cent.

Ending the scourge of measles

Ending the scourge of measles

Rediff.com29 May 2019

Vaccination against measles has been declining steadily over the last ten years in India. This must be reversed in order to avoid a serious outbreak of the disease, says Phalasha Nagpal.

Centre issues norms for administering measles, rubella vaccines to kids

Centre issues norms for administering measles, rubella vaccines to kids

Rediff.com23 Nov 2022

In a letter to the principal health secretary of Maharashtra that was also marked to all states and Union Territories (UTs), the Union Health Ministry said this surge is of particular concern from the public health point of view.

Centre sends high-level team to Mumbai to manage measles outbreak

Centre sends high-level team to Mumbai to manage measles outbreak

Rediff.com10 Nov 2022

The team will assist the state health authorities in instituting public health measures and facilitate operationalisation of requisite control and containment measures, it said.

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

1-year-old is Mumbai's 7th measles death, 164 cases so far in city

1-year-old is Mumbai's 7th measles death, 164 cases so far in city

Rediff.com17 Nov 2022

With 184 new cases having symptoms of fever and rashes on the body, the number of suspected measles cases in the city rose to 1,263, and 647 of these cases included children in the age group of 1 to 4 years, the BMC said in a release on Wednesday.

Coronavirus fallout: 5 million children missed vaccination in March

Coronavirus fallout: 5 million children missed vaccination in March

Rediff.com27 Apr 2020

A dipstick survey covering 30 villages in Rajasthan threw up some worrisome numbers. About 250 children missed their regular vaccination schedule in March alone. These numbers are alarming, since India has around 600,000 villages according to the 2011 census. Sohini Das reports.

COVID-19: Why everyone needs to be vaccinated

COVID-19: Why everyone needs to be vaccinated

Rediff.com23 Feb 2021

'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.' 'Most of those people, who got infected this year, will be next year back to level zero -- once again susceptible.'

'All the vaccines, so far, seem to be protecting from severe illness'

'All the vaccines, so far, seem to be protecting from severe illness'

Rediff.com9 Nov 2021

'The immune protection may well wane somewhat, and that's what we have to monitor.' 'Should it wane to the point where vaccinated individuals are getting severe disease, then we really will need to give them booster shots and that'll apply regardless of what vaccine they've got the first time.'

How to STAY SAFE after Vaccination

How to STAY SAFE after Vaccination

Rediff.com6 Jul 2021

'Chances of getting the disease are not reduced, either after one dose or both doses of the vaccine.' 'And the probability of getting the infection -- you need to differentiate infection from disease -- by getting vaccinated is almost unaltered, be it single dose or two doses.' 'But your chances of developing moderate to severe disease, after getting infected, gets reduced with every dose you receive.'

Serum Institute began its journey in a small lab in stud farm

Serum Institute began its journey in a small lab in stud farm

Rediff.com16 Jan 2021

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.

Meet Adar Poonawala, India's COVID-19 vaccine man

Meet Adar Poonawala, India's COVID-19 vaccine man

Rediff.com6 Aug 2020

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine. Sohini Das profiles its 39-year-old CEO.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

Govt to repurpose CoWIN to include all vaccination

Govt to repurpose CoWIN to include all vaccination

Rediff.com27 May 2022

The Universal Immunisation Programme is one of the largest vaccination projects in the world aimed at protecting children and pregnant mothers from preventable diseases. Under it, the government provides shots for 12 vaccine-preventable diseases, such as polio, diphtheria, tetanus, measles, and hepatitis B, for free.

Padma Bhushan for Indian vaccine makers

Padma Bhushan for Indian vaccine makers

Rediff.com25 Jan 2022

Microsoft Chairman and CEO Satya Nadella along with Alphabet Inc and its subsidiary Google CEO Sundararajan Pichai are also among those from trade and industry who have been awarded the Padma Bhushan for their distinguished services.

Serum Institute to produce COVID-19 vaccine by yearend

Serum Institute to produce COVID-19 vaccine by yearend

Rediff.com7 May 2020

'The challenge will be making sure its efficacy is high.' 'If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.'

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

Dry run for COVID-19 vaccine concludes successfully

Dry run for COVID-19 vaccine concludes successfully

Rediff.com29 Dec 2020

The end-to-end exercise was undertaken in Krishna district of Andhra Pradesh, Rajkot and Gandhinagar of Gujarat, Ludhiana and Shaheed Bhagat Singh Nagar of Punjab, and Sonitpur and Nalbari districts of Assam on Monday and Tuesday.

Do adults need vaccination?

Do adults need vaccination?

Rediff.com22 Aug 2015

Adults are as likely as children to fall prey to diseases that immunisation can potentially prevent.

Stop vaccine nationalism: Jaishankar at UNSC meeting

Stop vaccine nationalism: Jaishankar at UNSC meeting

Rediff.com17 Feb 2021

India, which has shipped 'Made In India' COVID-19 vaccines to around 25 nations, on Wednesday urged the international community to stop 'vaccine nationalism' and actively encourage 'internationalism', underlining that hoarding superfluous doses will defeat global efforts to attain collective health security and combat the pandemic.

Govt to expand vaccination drive in coming days: Vardhan

Govt to expand vaccination drive in coming days: Vardhan

Rediff.com19 Mar 2021

Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.

Why Modi visited Serum's Covid vaccine unit

Why Modi visited Serum's Covid vaccine unit

Rediff.com10 Dec 2020

The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.

'Both vaccines will be similar in immunity'

'Both vaccines will be similar in immunity'

Rediff.com11 Jan 2021

'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Rediff.com14 Jul 2020

Since India is one of the largest vaccine producers in the world, it is the country's 'moral responsibility' to fast-track vaccine development process to break the chain of coronavirus transmission, ICMR Director General Dr Balram Bhargava said referring to the two vaccine candidates developed indigenously.

UNICEF to lead global procurement, supply of COVID-19 vaccines

UNICEF to lead global procurement, supply of COVID-19 vaccines

Rediff.com7 Sep 2020

The UNICEF is the world's largest single vaccine buyer, procuring more than 2 billion doses of various vaccines annually for routine immunisation and outbreak response on behalf of nearly 100 countries.

Serum to produce up to 100 mn Covid vaccine doses for India, others

Serum to produce up to 100 mn Covid vaccine doses for India, others

Rediff.com7 Aug 2020

The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.

Four children die after vaccination in Lucknow

Four children die after vaccination in Lucknow

Rediff.com21 Aug 2010

Four children died during a routine vaccination drive in three different villages of Mohanlalganj area on the outskirts of Lucknow on Saturday."Minutes after being administered doses for prevention of measles, tuberculosis and Vitamin A deficiency, these children developed a strange kind of sickness. By the time they were rushed to the nearest hospital, they were dead," said District Magistrate Anil Kumar Sagar.

Please note: Life after vaccine won't be normal

Please note: Life after vaccine won't be normal

Rediff.com20 Dec 2020

'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'

Serum Institute to start Oxford vaccine candidate trial by Aug end

Serum Institute to start Oxford vaccine candidate trial by Aug end

Rediff.com21 Jul 2020

The Pune-based company's chief executive Adar Poonawalla said the company, which is the largest vaccine maker in the world, is putting $200 million at risk by manufacturing nearly 300 million doses before the final nod to launch the vaccine in market, which is expected at best by the end of the year.

2nd dry run of vaccine: Vardhan reviews preparations across states

2nd dry run of vaccine: Vardhan reviews preparations across states

Rediff.com7 Jan 2021

Union Health Minister Harsh Vardhan on Thursday sought keen oversight and personal indulgence of health ministers, principal secretaries and additional chief secretaries of states and union territories to lead the second nationwide mock drill on the COVID-19 vaccination scheduled to be held on January 8.

Covid vaccine to be available for every Indian till 2024: Poonawalla

Covid vaccine to be available for every Indian till 2024: Poonawalla

Rediff.com19 Nov 2020

Poonawalla said the price will be around USD 5-6 per dose with an MRP of around Rs 1,000 for the two necessary doses.

Reliance, Tata on TIME's list of world's most influential companies

Reliance, Tata on TIME's list of world's most influential companies

Rediff.com30 May 2024

Billionaire Mukesh Ambani's Reliance Industries and Tata Group have made it to the prestigious TIME's list of 100 World's Most Influential Companies of 2024. TIME called Reliance 'India's Juggernaut'. This is the second time that Reliance has found its way into the TIME list. Jio Platforms, the firm that holds digital properties of the conglomerate, was included in the inaugural TIME 100 Most Influential Companies List of 2021. Serum Institute is the other Indian company on the list.

'No need to give special attention to COVID-19 anymore'

'No need to give special attention to COVID-19 anymore'

Rediff.com22 Aug 2022

'All actions for COVID-19 should be the same as for other routine health conditions.' 'There is no need to report the matter in the media all the time; not on front page please.'

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

'Covid virus is getting weaker'

'Covid virus is getting weaker'

Rediff.com15 Dec 2020

'If at all there is going to be a second wave, it will not be very strong unlike in the US and Europe.'

'Vaccine shortage can't be blamed on Adar Poonawalla'

'Vaccine shortage can't be blamed on Adar Poonawalla'

Rediff.com16 Aug 2021

'It was unfair to expect him to continue to keep on supplying vaccines without being given a firm commitment or a financial grant of any sort.'

Voting For Trump Will Only Hurt America

Voting For Trump Will Only Hurt America

Rediff.com5 Nov 2024

'To everyone voting for Trump, I have only this simple question: Would you let him have lunch with your daughter or sister or wife or mother?' 'Then why would you let him have our lunch (and so much more) for four more years?', asks Sree Sreenivasan.